INTRODUCTION {#s1}
============

Breast carcinoma is the leading cause of cancer death in women worldwide \[[@R1]\]. According to the GLOBOCAN 2018 worldwide estimates of cancer incidence and mortality, in 2018, about 2,088,849 new cases were diagnosed and approximately 626,679 women were predicted to die from the disease \[[@R2]\]. These data support the need to develop more efficient strategies for preventive intervention, evaluation of therapy, and prediction of prognosis \[[@R3]\].

Undoubtedly, TNM staging is of great prognostic value; however, considering all the limitations of the currently available prognostic strategies, it is overall recognized that new affordable more accurate methods indicative of molecular characteristics of tumors are needed to achieve personalized treatment \[[@R4]\]. Still, it remains difficult to achieve these goals, because of the absence of refined (sensitive and specific) biomarkers for disease monitoring and for addressing breast cancer on an individual basis.

MicroRNAs are a small class of endogenous, evolutionarily conserved, single-stranded noncoding RNAs, with a length of approximately 19--24 nucleotides \[[@R5]\]. Interaction between miRNAs and mRNAs, within the 3′untranslated region of the target genes, leads to the degradation or inhibition of mRNA translation \[[@R6]\]. In the past few years, miRNAs have attracted considerable attention in the cancer research field, due to their regulatory actions in multiple levels \[[@R7], [@R8]\]. Depending on the target gene that they regulate, miRNAs can either serve as "tumor suppressor miRs" by repressing oncogenes or as "onco-miRs" by targeting tumor suppressor genes. However, a number of miRNAs play both tumor suppressor and onco-miR roles depending on the cellular context and tumor type \[[@R9]\].

Particularly in breast cancer, microRNAs (miRNAs or miRs) have been proposed as promising biomarkers because they can be readily detected in tumor biopsies (non-circulating miRNAs) and can also be identified in blood, plasma, serum, and saliva (circulating miRNAs) \[[@R10]\]. Furthermore, circulating miRNAs are bound to lipoproteins such as HDL, are associated with Argonaute 2 (Ago2) protein, or are packaged into exosome-like microparticles, micro-vesicles, and apoptotic bodies \[[@R11]\]. Therefore, they are protected from endogenous RNAase activity, and hence they are reliable.

Several lines of evidence have proven that in breast cancer, the expression levels of miRNAs are altered due to key mechanisms, such as epigenetic control, transcription factors, or the effect of mutated proteins \[[@R10]\]. According to previous publications \[[@R12]\], miRNAs are considered as tumor suppressive or protective when they are down-regulated in cancer compared to their normal counterpart, or else, they are termed oncogenic miRNAs or onco-miRs. In this context, miRNAs are increasingly recognized as promising biomarkers, given the fact that they are easy to isolate, and they maintain their structural stability under different conditions of sample processing and isolation. A prognostic biomarker should indicate a patient's outcome, for example disease recurrence or disease progression, independent of the treatment regimen that was followed, and they are highly desirable for personalized or precise patient treatment \[[@R13]\].

The aim of the present review is to highlight recent preclinical and clinical studies performed on both circulating and tissue-specific miRNAs and therefore to identify their potential role as prognostic markers in breast cancer. We will particularly focus on the potential role of miRNAs in breast cancer prognosis, and on how miRNAs have the potential to answer actual clinical needs, such as identification of biomarkers for prognosis, in order to achieve the goal of individualized breast cancer treatment.

RESULTS {#s2}
=======

The search strategy retrieved 192 articles. Of these articles, 42 were irrelevant, 11 were reviews, eight (8) were meta-analyses, six (6) were retracted articles, three (3) were not in English, three (3) were duplicates, two (2) were comments and 117 were eligible. The aforementioned steps concerning the selection of studies are illustrated in detail in [Figure 1](#F1){ref-type="fig"}. Therefore, a total of 117 articles were eligible for this systematic review and the prognostic role of 110 miRNA molecules is described ([Table 1](#T1){ref-type="table"}). Furthermore, we retrieved five studies, in which authors have identified six distinct microRNA signatures with prognostic value in breast cancer ([Table 2](#T2){ref-type="table"}).

![Flow diagram of the study selection process](oncotarget-10-7156-g001){#F1}

###### List of prognostic microRNAs in breast cancer

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Prognostic microRNA   Breast cancer type   Detection method               Prognostic value                   Role               Biological sample    References
  --------------------- -------------------- ------------------------------ ---------------------------------- ------------------ -------------------- ------------------------------------
  let-7                 BC not\              qRT-PCR                        potential prognostic\              tumor\             serum                \[[@R56]\]
                        classified                                          biomarker as altered levels\       suppressor                              
                                                                            of miR-let-7 are associated\                                               
                                                                            with metastases risk                                                       

  let-7-3p              TNBC                 NGS, qRT-\                     independent prognostic\            onco-miR           FFPE                 \[[@R57]\]
                                             PCR                            factor for OS, DFS                                                         

  let-7b                luminal subtype      qRT-PCR,\                      independent prognostic\            tumor\             FFPE                 \[[@R58]\]
                                             LNA-ISH,\                      factor for OS associated\          suppressor                              
                                             TMAs                           with luminal tumors                                                        

  let-7c/miR-\          estrogen-\           Nanostring,\                   potential prognostic factor\       tumor\             cell lines           \[[@R59]\]
  99a/miR-125b\         dependent\           qRT-PCR,\                      for OS in the luminal A\           suppressor                              
  cluster               BC cell line         luciferase assay               subtype                                                                    

  miR-1                 ER-positive,\        PCR,\                          independent worse\                 onco-miR           FFPE                 \[[@R60]\]
                        stage IV BC          microarray,\                   prognostic factor of DFS\                                                  
                                             ISH, IHC                       and BC-specific survival\                                                  
                                                                            associated with stage,\                                                    
                                                                            lymph node metastasis,\                                                    
                                                                            distant metastasis,\                                                       
                                                                            histological grade, ER\                                                    
                                                                            status, PR status and Ki-67                                                

  miR-7                 BC not\              qRT-PCR                        potential prognostic factor\       onco-miR           fresh frozen\        \[[@R61]\]
                        classified                                          for OS, DFS predictive\                               tissue, cell lines   
                                                                            of an adverse response to\                                                 
                                                                            tamoxifen therapy                                                          

  miR-9                 TNBC,\               qRT-PCR                        prognostic factor of DFS\          onco-miR           FFPE, fresh\         \[[@R62], [@R63]\]
                        BC not\                                             and DMFS, OS                                          frozen tissue,\      
                        classified                                                                                                cell lines           

  miR-10b               BC not\              qRT-PCR                        independent prognostic\            onco-miR           FFPE, fresh\         \[[@R17], [@R40], [@R41], [@R64]\]
                        classified,\                                        factor for DFS associated\                            frozen tissue,\      
                        TNBC                                                with distant metastasis,\                             cell lines           
                                                                            occurrence in TNBC,\                                                       
                                                                            associated with genico-\                                                   
                                                                            obstetric history                                                          

  miR-15a               TNBC                 qRT-PCR                        prognostic factor for OS,\         tumor\             fresh frozen\        \[[@R65]\]
                                                                            DFS                                suppressor         tissue               

  miR-16                triple\              qRT-PCR,\                      potentially tumor\                 tumor\             FFPE                 \[[@R45]\]
                        possitive\           Western blot,\                 suppressive effect on\             suppressor                              
                        BC                   luciferase\                    cancer progression of ER\                                                  
                                             report assay,\                 positive breast cancers,\                                                  
                                             MTS assay                      impairment of cell proliferation                                           

  miR-19a               newly\               qRT-PCR                        potential prognostic factor\       tumor\             serum, cell\         \[[@R66]\]
                        diagnosed\                                          for OS, DFS in patients\           suppressor         lines                
                        IBC stage\                                          with metastatic HER2(+)\                                                   
                        III, IBC\                                           IBC.                                                                       
                        stage IV,\                                                                                                                     
                        non-IBC\                                                                                                                       
                        stage II-IV\                                                                                                                   
                        and HER2+\                                                                                                                     
                        BC                                                                                                                             

  miR-19b               BC not\              qRT-PCR                        prognostic factor for OS\          onco-miR           fresh frozen\        \[[@R67]\]
                        classified                                          associated with distant\                              tissue, cell lines   
                                                                            metastasis and TNM stage                                                   

  miR-20b-5p            BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS, correlated with\                             interstitial\        
                                                                            the presence of breast\                               breast tumor\        
                                                                            tumor interstitial fluid                              fluids, serum        

  miR-21                stage II/III\        qRT-PCR,\                      independent prognostic\            onco-miR           FFPE, serum,\        \[[@R16]-[@R27]\]
                        BC, HER2\            microarray,\                   factor of OS, DFS,\                                   fresh frozen\        
                        positive, TNBC       luciferase\                    prognostic biomarker for\                             tissue, cell lines   
                                             report assay                   resistance to trastuzumab,\                                                
                                                                            to predict lymph node\                                                     
                                                                            metastases occurrence\                                                     
                                                                            in TNBC, to predict\                                                       
                                                                            high grade in non TNBC\                                                    
                                                                            possible, prognostic factor\                                               
                                                                            in daughter of patients,\                                                  
                                                                            associated with genico-\                                                   
                                                                            obstetric history                                                          

  miR-22                BC not\              qRT-PCR,\                      potential prognostic factor\       both               FFPE, cell lines     \[[@R69], [@R70]\]
                        classified           ISH, luciferase\               for OS, DFS, associated\                                                   
                                             report assay                   with EMT/metastasis                                                        

  miR-24-2\*.           BC cell\             qRT-PCR                        associated with tumor\             tumor\             cell lines, fresh\   \[[@R71]\]
                        lines                                               suppressive activity\              suppressor         frozen mouse\        
                                                                            through the suppression of\                           tissue               
                                                                            cellular survival                                                          

  mir-24-3p             BC not\              Nanostring\                    potential prognostic\              onco-miR           plasma               \[[@R72]\]
                        classified\          technology                     biomarker of occult\                                                       
                        (stage I-III)                                       metastasis                                                                 

  miR-27a               BC not\              ISH, IHC                       independent prognostic\            onco-miR           FFPE                 \[[@R73]\]
                        classified                                          factor for OS, DFS                                                         

  miR-27b-3p            TNBC                 qRT-PCR                        independent prognostic\            onco-miR           FFPE                 \[[@R74]\]
                                                                            factor for OS, DMF survival                                                

  miR-29a               BC not\              qRT-PCR,\                      asocciated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    

  miR-29b               lobular\             qRT-PCR                        prognostic factor for OS,\         tumor\             fresh frozen\        \[[@R76], [@R77]\]
                        and ductal\                                         DFS                                suppressor         tissue               
                        subtypes                                                                                                                       

  miR-30a               TNBC                 NGS,\                          independent prognostic\            tumor\             FFPE, cell lines     \[[@R57], [@R78]\]
                                             qRT-PCR,\                      factor for OS, DFS                 suppressor                              
                                             microarray, luciferase assay                                                                              

  miR-30a-3p            TNBC                 qRT-PCR                        prognostic factor for OS,\         tumor\             FFPE                 \[[@R57]\]
                                                                            RFS                                suppressor                              

  miR-30a-5p            TNBC                 NGS                            prognostic factor for OS,\         tumor\             FFPE                 \[[@R57]\]
                                                                            RFS                                suppressor                              

  miR-30c-5p            TNBC                 qRT-PCR                        prognostic factor for\             tumor\             FFPE                 \[[@R57]\]
                                                                            RFS                                suppressor                              

  miR-30e\*             ESR1-/\              microarray,\                   prognostic factor for DFS          tumor\             fresh frozen\        \[[@R79]\]
                        ERBB2-\              ISH                                                               suppressor         tissue               
                        tumors                                                                                                                         

  miR-34a               BC not\              qRT-PCR,\                      prognostic factor for OS,\         both               FFPE, plasma,\       \[[@R75], [@R80], [@R81]\]
                        classified\          TMAs                           associated with response\                             cell lines           
                        TNBC                                                and chemotherapy\                                                          
                                                                            resistance                                                                 

  miR-34b               TNBC                 qRT-PCR                        prognostic factor for OS,\         onco-miR           FFPE                 \[[@R82]\]
                                                                            DFS                                                                        

  miR-34c               TNBC                 qRT-PCR                        independent risk factor\           tumor\             Plasma               \[[@R81]\]
                                                                            for OS                             suppressor                              

  miR-93-5p             BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS, correlated with\                             interstitial\        
                                                                            the presence of breast\                               breast tumor\        
                                                                            tumor interstitial fluid                              fluids, serum        

  miR-95-3p             TNBC                 qRT-PCR                        prognostic factor for OS,\         onco-miR           FFPE                 \[[@R57]\]
                                                                            RFS in patients treated\                                                   
                                                                            with anthracycline-based\                                                  
                                                                            chemotherapy                                                               

  miR-96                BC cell\             qRT-PCR                        potential prognostic factor\       onco-miR           cell lines           \[[@R44]\]
                        lines                                               for OS associated with\                                                    
                                                                            EMT and regulation of\                                                     
                                                                            growth factors involved in\                                                
                                                                            G1/S-phase transition                                                      

  miR-99a               BC not\              qRT-PCR                        potential prognostic factor\       tumor\             serum                \[[@R83]\]
                        classified                                          for OS, independent risk\          suppressor                              
                                                                            factor for breast cancer                                                   

  miR-122               BC not\              qRT-PCR,\                      potential prognostic\              onco-miR           serum                \[[@R84]\]
                        classified\          NGS                            factor for disease relapse,\                                               
                        (stage II-III)                                      predictor of metastasis                                                    

  miR-124               BC not\              qRT-PCR                        prognostic factor for\             tumor\             FFPE, fresh\         \[[@R85], [@R86]\]
                        classified                                          OS associated with\                suppressor         frozen tissue        
                                                                            advanced TNM stage,\                                                       
                                                                            lymph node metastasis\                                                     
                                                                            and poorer pathological\                                                   
                                                                            differentiation, associated\                                               
                                                                            with age at diagnosis (\>50\                                               
                                                                            years old)                                                                 

  miR-125a-5p           BC not\              microarray,\                   potential prognostic factor\       tumor\             serum, cell\         \[[@R87]\]
                        classified           qRT-PCR,\                      for OS, progression-free\          suppressor         lines                
                                             luciferase\                    survival (PRS)                                                             
                                             assay, ISH,\                                                                                              
                                             IHC                                                                                                       

  miR-125b              HER2\                qRT-PCR, ISH                   prognostic factor for\             onco-miR           FFPE, serum,\        \[[@R26], [@R88], [@R89]\]
                        positive BC,\                                       OS, DFS, associated\                                  cell lines           
                        stage II/III                                        with aromatase inhibitor\                                                  
                                                                            esistant breast cancers                                                    

  miR-126-5p            BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS                                               interstitial\        
                                                                                                                                  breast tumor\        
                                                                                                                                  fluids, serum        

  miR-127               BC not\              qRT-PCR                        prognostic factor of OS            tumor\             fresh frozen\        \[[@R90]\]
                        classified                                                                             suppressor         tissue, cell lines   

  miR-128-3p            TNBC                 qRT-PCR                        prognostic factor for RFS          tumor\             FFPE                 \[[@R57]\]
                                                                                                               suppressor                              

  miR-129-5p            BC not\              qRT-PCR,\                      potential prognostic factor\       tumor\             FFPE, fresh\         \[[@R91]\]
                        classified           luciferase\                    for OS, DFS, associated\           suppressor         frozen tissue,\      
                                             report assay                   with EMT                                              cell lines           

  miR-133a              BC not\              qRT-PCR,\                      potential prognostic factor\       tumor\             FFPE, fresh\         \[[@R92]\]
                        classified           TMA, ISH,\                     for DFS associated with\           suppressor         frozen tissue,\      
                                             Luciferase assay               migration and invasion                                cell lines           

  miR-140               BC not\              qRT-PCR,\                      asocciated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    

  miR-141               BC not\              microRNA\                      potential prognostic factor\       onco-miR           plasma               \[[@R33], [@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS associated\                                                    
                                             PCR                            with circulating tumor\                                                    
                                                                            cells status                                                               

  miR-143               Triple\              qRT-PCR,\                      potentially tumor\                 tumor\             FFPE                 \[[@R45]\]
                        possitive\           Western blot,\                 suppressive effect on\             suppressor                              
                        BC                   luciferase\                    cancer progression of ER\                                                  
                                             report assay,\                 positive breast cancers,\                                                  
                                             MTS assay                      impairment of cell\                                                        
                                                                            proliferation                                                              

  miR-144               BC not\              microRNA\                      potential prognostic factor\       tumor\             plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS                        suppressor                              
                                             PCR                                                                                                       

  miR-145               BC not\              qRT-PCR                        potential prognostic factor\       tumor\             fresh frozen\        \[[@R93], [@R94]\]
                        classified                                          for DFS, OS (3-year\               suppressor         tissue               
                                                                            survival rate)                                                             

  miR-146a              BRCA1-\              qRT-PCR                        potential prognostic factor\       tumor\             FFPE, cell lines     \[[@R95]\]
                        deficient\                                          for OS                             suppressor                              
                        TNBC\                                                                                                                          
                        tumors                                                                                                                         

  miR-148a              TNBC                 qRT-PCR,\                      potential prognostic factor\       tumor\             Cell lines,\         \[[@R96]\]
                                             microarray                     for OS associated with\            suppressor         mouse models         
                                                                            metastasis                                                                 

  miR-155               TNBC,\               qRT-PCR,\                      prognostic factor of\              both               FFPE, fresh\         \[[@R62], [@R97]\]
                        BC not\              microarray,\                   DMFS, associated with\                                frozen tissue,\      
                        classified           luciferase\                    lymph node metastasis                                 cell lines           
                                             report assay                                                                                              

  miR-182               BC not\              qRT-PCR                        potential prognostic factor\       onco-miR           FFPE, serum          \[[@R17], [@R98]\]
                        classified,\                                        to predict lymph node\                                                     
                        TNBC                                                metastases occurrence in\                                                  
                                                                            TNBC, associated with\                                                     
                                                                            genico-obstetric history,\                                                 
                                                                            related with hormonal\                                                     
                                                                            receptors                                                                  

  miR-183/182/96\       BC not\              qRT-PCR, ISH                   potential prognostic factor\       onco-miR           breast tissues\      \[[@R99]\]
  cluster               classified                                          for OS, DFS                                           not classified,\     
                                                                                                                                  cell lines           

  miR-187               BC not\              TMA, ISH                       independent prognostic\            onco-miR           FFPE, cell lines     \[[@R100]\]
                        classified                                          factor FOR breast cancer--\                                                
                                                                            specific survival (BCSS)                                                   

  miR-193b              BC not\              microRNA\                      potential prognostic factor\       onco-miR           plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS                                                                
                                             PCR                                                                                                       

  miR-195-5p            BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS                                               interstitial\        
                                                                                                                                  breast tumor\        
                                                                                                                                  fluids, serum        

  miR-199a-5p           TNBC                 NGS                            prognostic factor for OS           tumor\             FFPE                 \[[@R57]\]
                                                                                                               suppressor                              

  miR-199b-5p           BC not\              qRT-PCR,\                      potential prognostic factor\       tumor\             fresh frozen\        \[[@R101]\]
                        classified\          assays in vitro                for OS associated with\            suppressor         tissue and cell\     
                        (-II stage)                                         TNM stage and lymph\                                  lines                
                                                                            node metastasis                                                            

  miR-200a              BC not\              microRNA\                      potential prognostic factor\       onco-miR           plasma               \[[@R33], [@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS, associated\                                                   
                                             PCR                            with circulating tumor\                                                    
                                                                            cells status, potential\                                                   
                                                                            to detect the onset of\                                                    
                                                                            metastasis                                                                 

  miR-200b              BC not\              qRT-PCR,\                      potential prognostic factor\       both               FFPE, plasma,\       \[[@R33], [@R34], [@R46], [@R47]\]
                        classified           microRNA\                      for OS (independent),\                                cell lines           
                                             arrays,\                       PFS associated with\                                                       
                                             ISH, TMA,\                     advanced clinical\                                                         
                                             luciferase\                    stage, metastasis, cell\                                                   
                                             report assay                   proliferation, apoptosis,\                                                 
                                                                            cell cycle distribution and\                                               
                                                                            circulating tumor cells\                                                   
                                                                            status, potential to detect\                                               
                                                                            the onset of metastasis                                                    

  miR-200c              BC not\              qRT-PCR,\                      prognostic factor of OS,\          onco-miR           fresh frozen\        \[[@R33], [@R34], [@R102]\]
                        classified           microRNA\                      DFS, potential to detect\                             tissue, plasma       
                                             arrays                         the onset of metastasis,\                                                  
                                                                            associated with circulating\                                               
                                                                            tumor cells status                                                         

  miR-200c/141\         BC not\              qRT-PCR,\                      poor prognostic factor\            onco-miR           FFPE, cell\          \[[@R103]\]
  cluster               classified,\         CAT reporter\                  in TNBC, promoting\                                   lines, xenograft\    
                        TNBC                 assay, siRNA\                  metastasis                                            animal model         
                                             transfection,\                                                                                            
                                             Western blot                                                                                              

  miR-203               BC not\              microRNA\                      potential prognostic factor\       both               FFPE, plasma,\       \[[@R33], [@R34], [@R44], [@R45]\]
                        classified,\         arrays, qRT-\                  for OS, PFS associated\                               cell lines           
                        ER positive\         PCR, Western\                  with EMT and circulating\                                                  
                        BC                   blot, luciferase\              tumor cells status                                                         
                                             report assay,\                                                                                            
                                             MTS assay                                                                                                 

  miR-203-5p            TNBC                 NGS                            prognostic factor for OS           onco-miR           FFPE                 \[[@R57]\]

  miR-203a              ductal\              qRT-PCR                        potential prognostic\              tumor\             FFPE                 \[[@R104]\]
                        in situ,\                                           marker associated with\            suppressor                              
                        invasive\                                           increased stage in invasive\                                               
                        ductal and\                                         lobular carcinomas                                                         
                        lobular carcinoma                                                                                                              

  miR-204               BC not\              qRT-PCR                        potential prognostic factor\       tumor\             FFPE                 \[[@R105]\]
                        classified                                          for OS, DFS, correlated\           suppressor                              
                                                                            with chemotherapeutic\                                                     
                                                                            resistance                                                                 

  miR-205               BC not\              qRT-PCR,\                      potential prognostic\              tumor\             FFPE                 \[[@R21], [@R58]\]
                        classified           LNA-ISH,\                      factor for OS associated\          suppressor                              
                                             TMAs, IHC                      with tumours of ductal\                                                    
                                                                            morphology, for OS and\                                                    
                                                                            DFS in early breast cancer                                                 

  miR-206               BC not\              qRT-PCR,\                      potential prognostic factor\       both               fresh frozen\        \[[@R94], [@R106], [@R107],
                        classified           luciferase\                    for OS                                                tissue, cell lines   
                                             report assay                                                                                              

  miR-210               early first\         qRT-PCR,\                      independent prognostic\            onco-miR           FFPE, fresh\         \[[@R33]-[@R39]\]
                        primary BC,\         microarray                     factor for OS, DFS,\                                  frozen tissue,\      
                        TNBC                                                associated with poor\                                 plasma, cell\        
                                                                            clinical outcome in ER-\                              lines (Breast\       
                                                                            positive, tamoxifen-treated\                          cancer and\          
                                                                            BC patients, involved\                                tumor-educated\      
                                                                            in cell proliferation,\                               macrophages)         
                                                                            migration and invasion,\                                                   
                                                                            Potential to detect the\                                                   
                                                                            onset of metastasis prior\                                                 
                                                                            to clinical diagnosis,\                                                    
                                                                            associated with circulating\                                               
                                                                            tumor cells status                                                         

  miR-210-3p            BC cell\             qRT-PCR                        potential prognostic factor\       onco-miR           cell lines           \[[@R44]\]
                        lines                                               for OS associated with\                                                    
                                                                            EMT and regulation of\                                                     
                                                                            growth factors involved in\                                                
                                                                            G1- to S-phase transition                                                  

  miR-215               BC not\              microRNA\                      potential prognostic factor\       tumor\             plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS, Potential\            suppressor                              
                                             PCR                            to detect the onset of\                                                    
                                                                            metastasis prior to clinical\                                              
                                                                            diagnosis                                                                  

  miR-218               BC not\              qRT-PCR                        prognostic factor for OS\          tumor\             fresh frozen\        \[[@R108]\]
                        classified                                          associated with lymph\             suppressor         tissue               
                                                                            node metastases, higher\                                                   
                                                                            grades,                                                                    

  miR-221               BC not\              qRT-PCR                        prognostic factor for DFS,\        onco-miR           FFPE, fresh\         \[[@R41], [@R63], [@R109]\]
                        classified                                          OS, RFS                                               frozen tissue,\      
                                                                                                                                  cell lines           

  miR-221-3p            TNBC                 qRT-PCR                        prognostic factor for DFS          tumour\            FFPE, cell lines     \[[@R110]\]
                                                                                                               suppressor                              

  miR-222               BC not\              qRT-PCR,\                      potential prognostic\              onco-miR           FFPE, fresh\         \[[@R75], [@R109]\]
                        classified           TMA                            factor related to lymph\                              frozen tissue,\      
                                                                            node metastasis, down-\                               cell lines           
                                                                            regulation of the estrogen\                                                
                                                                            receptor, EMT, tumor\                                                      
                                                                            progression, poor response\                                                
                                                                            and chemotherapy\                                                          
                                                                            resistance                                                                 

  miR-222-3p            BC not\              qRT-PCR,\                      independent prognostic\            onco-miR           serum                \[[@R111]\]
                        classified           microarray                     factor for DFS\                                                            
                                                                            postoperatively                                                            

  miR-301a              BC not\              qRT-PCR,\                      prognostic factor for DFS,\        onco-miR           FFPE                 \[[@R112], [@R113]\]
                        classified,\         microarray,\                   OS                                                                         
                        TNBC                 ISH                                                                                                       

  miR-320a              BC not\              chromogenic\                   potential prognostic factor\       tumor\             FFPE                 \[[@R114]\]
                        classified           ISH                            for OS for invasive breast\        suppressor                              
                                                                            cancer                                                                     

  miR-324-5p            TNBC                 NGS                            prognostic factor for OS           onco-miR           FFPE                 \[[@R57]\]

  miR-329               BC not\              qRT-PCR                        independent prognostic\            tumor-\            serum, fresh\        \[[@R115]\]
                        classified                                          factor for OS                      suppressor         frozen tissue,\      
                                                                                                                                  cell lines           

  miR-330-3p            BC not\              qRT-PCR                        potential prognostic factor\       onco-miR           fresh frozen\        \[[@R116]\]
                        classified                                          for OS                                                tissue               

  miR-339-5p            BC not\              qRT-PCR,\                      independent prognostic\            tumor\             FFPE, cell lines     \[[@R117]\]
                        classified           TMA, ISH                       factor for OS, DFS                 suppressor                              

  miR-361-5p            BC not\              TMAs, ISH                      prognostic factor for DFS          tumor\             FFPE                 \[[@R118]\]
                        classified, TNBC                                                                       suppressor                              

  miR-365               BC not\              microRNA\                      potential prognostic factor\       miR-365,\          plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS                             onco-miR                                
                                             PCR                                                                                                       

  miR-370               BC not\              qRT-PCR,\                      potential prognostic factor\       onco-miR           FFPE                 \[[@R119]\]
                        classified           TMA                            for DFS                                                                    

  miR-374a              BC not\              qRT-PCR,\                      potential prognostic factor\       onco-miR           FFPE, fresh\         \[[@R120], [@R121]\]
                        classified,\         TMAs,\                         for DFS, contributes\                                 frozen tissue,\      
                        IDC stage II         Luciferase\                    to tumorigenicity and\                                cell lines,\         
                                             assay, MTT\                    progression                                           xenograft\           
                                             assays, IHC                                                                          mouse models         

  miR-375               BC not\              qRT-PCR,\                      potential prognostic factor\       both               serum, plasma        \[[@R33], [@R34], [@R84], [@R98]\]
                        classified,\         microRNA\                      for OS, PFS associated\                                                    
                        stage II-III\        arrays, NGS                    with circulating tumor\                                                    
                        locally\                                            cells status, related to\                                                  
                        advanced\                                           hormonal receptors                                                         
                        and IBC\                                                                                                                       
                        patients                                                                                                                       

  miR-409-3p            BC not\              qRT-PCR                        independent prognostic\            tumor\             fresh frozen\        \[[@R112]\]
                        classified                                          factor for OS associated\          suppressor         tissue               
                                                                            with advanced TNM stage,\                                                  
                                                                            lymph node metastasis,\                                                    
                                                                            and poorer pathological\                                                   
                                                                            differentiation                                                            

  miR-423               BC not\              qRT-PCR,\                      asocciated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    

  miR-429               BC not\              microRNA\                      potential prognostic factor\       miR-429\           plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS                        onco-miR                                
                                             PCR                                                                                                       

  miR-451               BC cell\             qRT-PCR                        potential factor associated\       tumor\             cell lines           \[[@R123]\]
                        lines                                               with cell survival and\            suppressor                              
                                                                            endocrine resistance                                                       

  miR-454               BC not\              TMA, ISH                       potential prognostic\              onco-miR           FFPE                 \[[@R124]\]
                        classified\                                         factor for OS (especially\                                                 
                        (stage I-III)                                       in TNBC) and DFS,\                                                         
                                                                            associated with response\                                                  
                                                                            to anthracycline                                                           

  miR-454-3p            BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS                                               interstitial\        
                                                                                                                                  breast tumor\        
                                                                                                                                  fluids, serum        

  miR-486-5p            BC not\              microRNA\                      potential prognostic factor\       tumor\             plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS, Potential to detect\       suppressor                              
                                             PCR                            the onset of metastasis\                                                   
                                                                            prior to clinical diagnosis                                                

  miR-493               TNBC                 TMAs, ISH                      prognostic factor for DFS          tumour\            FFPE                 \[[@R125]\]
                                                                                                               suppressor                              

  miR-494               node-\               ISH                            8.5-fold risk of breast\           tumour\            fresh frozen\        \[[@R126]\]
                        negative BC                                         cancer death (association\         suppressor         tissue               
                                                                            trend-not clinical\                                                        
                                                                            significance)                                                              

  miR-497               BC not\              qRT-PCR,\                      potential prognostic factor\       tumor\             fresh frozen\        \[[@R127], [@R128]\]
                        classified,\         luciferase assay               for OS                             suppressor         tissue,\             
                        TNBC                                                                                                      cell lines,\         
                                                                                                                                  orthotopic\          
                                                                                                                                  mouse models         

  miR-548c-5p           TNBC                 qRT-PCR, ISH                   independent prognostic\            onco-miR           FFPE                 \[[@R39]\]
                                                                            factor for OS, DFS                                                         

  miR-574               BC not\              qRT-PCR,\                      asocciated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    

  miR-574-3p            BC not\              qRT-PCR,\                      potential prognostic factor\       tumor\             FFPE                 \[[@R129]\]
                        classified           NGS                            for OS, DFS                        suppressor                              

  miR-588               BC not\              qRT-PCR                        prognostic factor of OS            tumour\            fresh frozen\        \[[@R130]\]
                        classified                                                                             suppressor         tissue, cell lines   

  miR-590-3p            BC cell\             qRT-PCR,\                      associated with breast\            tumor\             cell lines           \[[@R131]\]
                        lines                luciferase\                    cancer cells viability,\           suppressor                              
                                             report assay                   growth and apoptosis                                                       

  miR-597               BC not\              qRT-PCR                        prognostic factor of OS            tumor\             fresh tissue         \[[@R132]\]
                        classified                                                                             suppressor                              

  miR-601               BC not\              qRT-PCR                        prognostic factor for\             tumor\             FFPE, cell lines     \[[@R133]\]
                        classified                                          DFS associated with\               suppressor                              
                                                                            cell proliferation and\                                                    
                                                                            metastasis                                                                 

  miR-638               BC not\              qRT-PCR                        independent prognostic\            tumor\             FFPE, fresh\         \[[@R95], [@R134]\]
                        classified,\                                        factor for OS associated\          suppressor         frozen, cell\        
                        BRCA1-\                                             with lymph node\                                      lines                
                        deficient\                                          metastasis and TNM stage                                                   
                        TNBC\                                                                                                                          
                        tumors                                                                                                                         

  miR-644a              BC cell\             qRT-PCR,\                      associated with tumor\             tumor\             cell lines           \[[@R135]\]
                        lines                luciferase\                    progression and distant\           suppressor                              
                                             report assay                   metastasis-free survival                                                   

  miR-660-5p            BC not\              qRT-PCR,\                      potential prognostic factor\       onco-miR           FFPE                 \[[@R129]\]
                        classified           NGS                            for OS, DFS                                                                

  miR-711               BC not\              qRT-PCR                        independent prognostic\            onco-miR           FFPE, cell lines     \[[@R136]\]
                        classified                                          factor for OS, DFS,\                                                       
                                                                            associated with breast\                                                    
                                                                            cancer cells' proliferation,\                                              
                                                                            colony formation, invasion                                                 

  miR-744               BC not\              qRT-PCR,\                      associated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    

  miR-801               BC not\              microRNA\                      potential prognostic factor\       onco-miR           plasma               \[[@R33], [@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS associated\                                                    
                                             PCR                            with circulating tumor\                                                    
                                                                            cells status                                                               

  miR-874               BC not\              qRT-PCR                        prognostic factor for OS           tumour\            fresh frozen\        \[[@R137]\]
                        classified                                                                             suppressor         tissue, cell lines   

  miR-940               IDC, TNBC            qRT-PCR                        prognostic factor for OS           tumor suppressor   serum                \[[@R138]\]

  miR-1179              BC not\              RT-PCR                         independent prognostic\            tumor\             breast tissue\       \[[@R139]\]
                        classified                                          factor for OS                      suppressor         not classified,\     
                                                                                                                                  cell lines           

  miR-1247-5p           BC not\              qRT-PCR                        independent prognostic\            tumor\             FFPE, fresh\         \[[@R140], [@R141]\]
                        classified                                          indicator for DFS, OS              suppressor         frozen tissue,\      
                                                                                                                                  cell lines           

  miR-1260              BC not\              microRNA\                      potential prognostic factor\       onco-miR           plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS                                                                     
                                             PCR                                                                                                       

  miR-1274a             BC not\              microRNA\                      potential prognostic factor\       onco-miR           plasma               \[[@R34]\]
                        classified           arrays, qRT-\                  for OS, PFS                                                                
                                             PCR                                                                                                       

  miR-1274b             BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS                                               interstitial\        
                                                                                                                                  breast tumor\        
                                                                                                                                  fluids, serum        

  miR-1825              BC not\              microRNA\                      potential prognostic factor\       onco-miR           FFPE,\               \[[@R68]\]
                        classified           arrays                         for DFS                                               interstitial\        
                                                                                                                                  breast tumor\        
                                                                                                                                  fluids, serum        

  miR-3178              BC not\              qRT-PCR,\                      associated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    

  miR-4653-3p           HR+ BC\              qRT-PCR                        potential prognostic\              tumor\             FFPE                 \[[@R142]\]
                        (stage I\~III)                                      biomarker for DFS for\             suppressor                              
                                                                            patients treated with\                                                     
                                                                            adjuvant tamoxifen                                                         

  miR-6780b             BC not\              qRT-PCR,\                      associated with\                   onco-miR           FFPE, cell lines     \[[@R75]\]
                        classified           microarray                     poor response and\                                                         
                                                                            chemotherapy resistance                                                    
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), In situ hybridization (ISH), locked nucleic acid probe in situ hybridization (LNA-ISH), Immunohistochemistry (IHC), epithelial-mesenchymal transition (EMT), formalin-fixed paraffin embedded (FFPE), Next Generation Sequencing (NGS), overall survival (OS), relapse free survival (RFS), disease free survival (DFS), progress free survival (PFS), breast cancer (BC), triple negative breast cancer (TNBC), Inflammatory breast cancer (IBC), Invasive Ductal Carcinoma (IDC), estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor type 2 (HER2).

###### List of prognostic microRNA signatures in breast cancer

  ------------------------------------------------------------------------------------------------------------------------------------
  miRNA signature   Breast cancer type   Detection method   Prognostic value   Role                   Biological sample   References
  ----------------- -------------------- ------------------ ------------------ ---------------------- ------------------- ------------
  miR-183-5p,\      BC not\              microarrays,\      potential\         miR-183-5p onco-miR\   FFPE                \[[@R48]\]
  miR-194-5p,\      classified           qRT-PCR            prognostic\        miR-194-5p onco-miR\                       
  miR-1285-5p\                                              factor for OS\     miR-1285-5p tumor\                         
  signature                                                 in young breast\   suppressor                                 
                                                            cancer patients\                                              
                                                            (age \<35 years)                                              

  miR-21, miR-\     HR\                  qRT-PCR            potential\         10-miRNA-based\        FFPE                \[[@R49]\]
  30c, miR-181a,\   positive,\                              prognostic\        classifier as a\                           
  miR-181c,\        HER2\                                   factor for DRFS    prognostic model                           
  miR-125b,\        negative                                                                                              
  miR-7, miR-\                                                                                                            
  200a, miR-\                                                                                                             
  135b, miR-22\                                                                                                           
  and miR-200c\                                                                                                           
  signature                                                                                                               

  miR-155, miR-\    TNBC                 qRT-PCR, IHC       potential\         miR-155 tumor\         FFPE                \[[@R50]\]
  493, miR-30e\                                             prognostic\        suppressor\                                
  and miR-27a\                                              factor for OS\     miR-493 tumor\                             
  signature                                                 associated\        suppressor\                                
                                                            with taxanes\      miR-30e onco-miR\                          
                                                            resistance         miR-27a onco-miR                           

  miR-16, 155,\     TNBC                 qRT-PCR            potential\         miR-16 tumor\          FFPE                \[[@R51]\]
  125b, 374a\                                               prognostic\        suppressor\                                
  signature                                                 factor for OS      miR-155 tumor\                             
                                                                               suppressor\                                
                                                                               miR-125b onco-miR\                         
                                                                               miR-374a tumor\                            
                                                                               suppressor                                 

  miR-16, 125b,\    TNBC                 qRT-PCR            potential\         miR-16 tumor\          FFPE                \[[@R51]\]
  374a, 374b,\                                              prognostic\        suppressor\                                
  421, 655, 497\                                            factor for DDFS    miR-125b onco-miR\                         
  signature                                                                    miR-374a tumor\                            
                                                                               suppressor\                                
                                                                               miR-374b tumor\                            
                                                                               suppressor\                                
                                                                               miR-421 onco-miR\                          
                                                                               miR-655 onco-miR\                          
                                                                               miR-497 tumor\                             
                                                                               suppressor                                 

  miR-191-5p,\      BC not\              qRT-PCR,\          independent\       miR-191-5p onco-miR\   FFPE, cell lines    \[[@R52]\]
  miR-214-3p,\      classified           microarray         prognostic\        miR-214-3p tumor\                          
  miR-451a,\                                                factor for OS,\    suppressor\                                
  and miR-489\                                              DFS                miR-451a tumor\                            
  signature                                                                    suppressor miR-489\                        
                                                                               tumor suppressor                           
  ------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: breast cancer (BC), quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR), formalin-fixed paraffin embedded (FFPE), overall survival (OS), distant disease-free survival (DDFS), distant recurrence free survival (DRFS).

According to our results, presented in [Table 1](#T1){ref-type="table"}, the majority of publications have not taken into account the distinct breast cancer subtypes during the development of their research protocol, since in 60.8% of studies breast cancer samples were not classified. The remaining 25.8% focused on Triple Negative Breast Cancer (TNBC) samples or involved Luminal A (5.0%), Luminal B (1.7%) and HER2-positive (1.7%) breast cancer samples. Of note, 5.0% of the selected studies accessed the prognostic value of miRNAs through experiments performed on breast cancer cell lines. Different detection methods, as well as different sample types were used for the detection of the prognostic miRNA expression levels (i.e., paraffin-fixed, formalin-fixed, freshly frozen tumors, plasma or serum). Concerning the detection methods, quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) was used in 35,8% of the eligible studies, while in 21,7% of the studies qRT-PCR was performed along with Microarray analysis. Additionally, next generation Sequencing technologies (9,2%), in situ hybridization techniques (9,2%), luciferase report assays (6,7%) or a combination of various techniques (10,8%) were employed.

DISCUSSION {#s3}
==========

We conducted a comprehensive systematic literature review to unfold the utility of miRNA biomarkers that can be evaluated for predicting prognosis in breast cancer patients. We have identified 117 studies that investigate the potential correlation between miRNA profile expression in breast cancer tissue and in the circulation and their possible use as prognostic factors. Interestingly, most of the miRNAs found to be associated with prognosis in breast cancer, were assessed in only a single study. Six miRs (miR-10b, miR-200b, miR-21, miR-203, miR-375, and miR-210) were evaluated in at least four studies and the discussion will be mainly focused on these molecules, based on an effort to merely provide some important information on the most commonly researched molecules in accordance with our systematic literature review.

MiR-21 is one of the most extensively studied cancer-related miRNAs and its aberrant expression and deregulation may play a pivotal role in the majority of cancers \[[@R14]\]. miR-21 may serve as a key regulator of oncogenic processes, including tumor growth, migration, and invasion \[[@R15]\], through targeting the pro-apoptotic phosphatase and tensin homolog (PTEN) and promoting tumor cell proliferation \[[@R16]\]. According to our initial search results, we retrieved 12 studies \[[@R16]-[@R27]\] and four meta-analyses \[[@R28]-[@R31]\] focusing on the prognostic value of miR-21, which collectively provide robust evidence that miR-21 up-regulation is associated with poor outcomes in cancer patients.

Mir-210 has multiple functions in cancer cells and is involved in angiogenesis, cell cycle regulation, DNA damage repair, mitochondrial metabolism, and immune response \[[@R32]\]. According to our search results, including seven studies \[[@R33]-[@R39]\], high expression of miR-210 has been significantly associated with poor survival in patients with breast cancer. Notably, single miR-210 assay has been proposed as an independent prognostic factor in this disease.

Concerning miR-10b, it has been presented as a potential biomarker that could play a predictive role in lymph node metastases occurrence across TNBC and in the incidence of high-grade tumors in non-TNBC cases \[[@R17]\]. Elevated expression of miR-10b in breast tumor tissue samples has been associated with adverse outcome, which is further supported from data derived from in vitro studies \[[@R40]\]. Finally, a survival analysis of 230 breast tissue samples has shown that high levels of miR-10b result to a short relapse free survival (RFS) of breast cancer, acting as an independent prognostic factor of RFS \[[@R41]\]. Our results, emphasize the oncogenic role of miR-10b and indicate that its high expression may be correlated with poor survival in breast cancer, while a recent metanalysis further strengthens our findings \[[@R30]\].

MiR-200 family members function as regulators of the epithelial to mesenchymal transition (EMT), which is one of the initial steps in tumor metastasis \[[@R42]\]. Specifically, miR-200b and miR-203 have both been characterized as tumor suppressors in multiple breast tumor types \[[@R43]\]. However, there seems to be an inconsistency in the existing literature, since we retrieved two studies that have found that higher expression of circulating miR-200b and miR-203 are associated with worse outcome \[[@R33], [@R34]\], further substantiated by a study on breast cancer cell lines \[[@R44]\]. However, other studies on breast cancer tissue samples and cell lines presented inverse results \[[@R45]-[@R47]\]. These discrepancies exhibit the diverse regulatory roles of miR-200 family members, depending on the cellular context and type of biological sample (blood VS tissue), and highlight the potential prognostic impact of these EMT regulating miRNA molecules in breast cancer.

Furthermore, our search retrieved five studies that have found six miRNA signatures to be useful for predicting the outcome of breast cancer \[[@R48]-[@R52]\]. Coordinated regulation of multiple miRNAs of potential prognostic value, has helped researchers identify panels of prognostic microRNAs for breast cancer. The discovery of microRNA expression signatures shows considerable promise for determining the prognosis of individuals with breast cancer. Similar miRNA signatures have been identified in a variety of other cancers, including acute myeloid leukemia, chronic lymphocytic leukemia, colon cancer, pancreatic cancer, and non-small cell lung cancer \[[@R53]\]. These reports highlight that this class of RNA molecules is showing substantial potential to be used as prognostic biomarkers for cancer.

Among the limitations of this effort, it should be stressed that this process was essentially driven by the search algorithm, which focused mainly on titles of the published literature, in an effort to provide more relevant results. Furthermore, clear heterogeneity was observed in our results, due to differences in patient characteristics (ethnicity, age, tumor stage, grade and subtype) and the use of different isolation and detection methods, cut-off values for miRNA expression levels, sample preparation methods and sample types (i.e., paraffin-fixed, formalin-fixed, freshly frozen tumors, plasma or serum).

Based on the results of this systematic review, we consider that miRNA detection may address the need for independent, easily accessible, prognostic molecular markers for breast cancer management in clinical practice, by assessing the impact of aberrant miRNA expression on patients' survival. Our work sums up all the available data on prognostic miRNAs and can also act as a valuable reference point for future studies. Furthermore, while prognostic studies can assist in answering important questions concerning specific patient outcomes, their vigorous and careful design is a necessary condition for ensuring the reliability of results \[[@R54]\]. It should be stressed out that the thorough validation of prognostic factors is a necessary and unavoidable process in order to maximize certainty in predicting future breast cancer patients' outcomes. Therefore, extensive validation studies focusing on particular miRNAs or miRNA signatures should be performed to relate baseline clinical and experimental variables to outcome. Eventually, all the reviewed molecular studies may help in bringing prognostic miRNAs closer to the clinical practice.

MATERIALS AND METHODS {#s4}
=====================

Methods of search strategy and study eligibility {#s4_1}
------------------------------------------------

This systematic review was conducted in accordance with the PRISMA guidelines \[[@R55]\] and in line with the a priori protocol agreed on and signed by EZ and FZ. Eligible studies were sought in PubMed without any restriction of publication language; the end-of-search date was January 28, 2019. The following search algorithm was used: breast\[ti\] AND (carcinoma OR carcinomas OR cancer OR cancers OR neoplasm OR neoplasms) AND (microRNA\[ti\] OR miR\[ti\] OR miRNA\[ti\] OR microRNAs\[ti\] OR miRs\[ti\] OR miRNAs\[ti\]) AND (prognosis\[ti\] OR prognostic\[ti\] OR survival\[ti\] OR outcome\[ti\] OR mortality\[ti\]). Eligible articles included studies examining the prognostic role of microRNAs in breast cancer. Only prospective and retrospective studies as well as case reports were considered eligible. In instances where multiple (overlapping) publications stemming from the same study were identified, the larger size study and the one with longer follow-up were included, unless the reported outcomes were mutually exclusive. Authors working independently and blindly to each other in pairs (E.Z., F.Z.) performed the selection of eligible studies; in case of disagreement, consensus with the whole team was reached.

Data extraction {#s4_2}
---------------

The extraction of data comprised general information, including the name of the miRNA molecule, the breast cancer type in which its expression was determined, method of detection, the sample type that was used, its prognostic value in breast cancer, its function in cancer (onco-miR or tumor suppressor-miR) and the author-year of publication. Data were independently extracted and analyzed by a pair of reviewers (E.Z. and F.Z.), with one reviewer being blinded to the other; if needed, the final decision was reached by a team consensus.

Eligible literature met the following criteria: (1) measured miR expression levels in tumor or blood samples or human cell lines and (2) only articles in English. Publications were excluded if they had one or more of the following criteria: (1) studies referring to the prognostic role of single nucleotide polymorphisms (SNPs) in miRNA genes affecting their function; (2) studies that refer to the prognostic role of target miRNA molecules (molecules regulated by miRs); (3) studies based solely on a bioinformatics approach or a computational algorithm, with survival data originated from databases without subsequent biological validation and (4) review papers, meta-analyses, comments, letters or duplicate publications.
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